You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Long-term outcome of patients with end stage chronic kidney disease taking low-dose aspirin
- In: Posters
- At: Dublin (Ireland) (2013)
- Type: Poster
- By: CHEN, Chung-Yu (Kaohsiung, China Taiwan)
- Co-author(s): Huang, Yaw-Bin (Graduate Institute of Clinical Pharmacy, Kaohsiung, China Taiwan)
- Abstract:
Background:
There are some data indicated that low-dose of aspirin using to be ineffective for ischemic stroke prevention on end stage chronic kidney disease (ESRD) patients. Therefore, we try to investigative the association of low-dose aspirin in terms of preventing death and readmission of stroke.
Methods:
This retrospective study identified.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026